EyePoint, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
EyePoint, Inc. (EYPT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$231.78 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-05
- EyePoint, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$231.78M.
- EyePoint, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$130.88M.
- EyePoint, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$70.81M.
- EyePoint, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$102.35M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|
| 2025-12-31 | -$231.78M 10-K · filed 2026-03-05 | |
| 2024-12-31 | -$130.88M 10-K · filed 2026-03-05 | |
| 2023-12-31 | -$70.81M 10-K · filed 2025-03-06 | |
| 2022-12-31 | -$102.35M 10-K · filed 2024-03-08 | |
| 2021-12-31 | -$58.52M 10-K · filed 2023-03-10 | |
| 2020-12-31 | -$45.49M 10-K · filed 2022-03-14 | |
| 2019-12-31 | -$56.87M 10-K · filed 2021-03-12 | |
| 2018-12-31 | -$44.80M 10-K · filed 2020-03-16 | |
| 2018-06-30 | -$53.00M 10-K · filed 2020-03-16 | |
| 2017-06-30 | -$17.57M 10-K · filed 2020-03-16 | |
| 2016-06-30 | -$19.78M 10-KT · filed 2019-03-18 | |
| 2015-06-30 | $8.12M 10-K · filed 2017-09-13 | |
| 2014-06-30 | -$11.71M 10-K · filed 2016-09-13 | |
| 2013-06-30 | -$10.10M 10-K · filed 2015-09-10 | |
| 2012-06-30 | -$11.21M 10-K · filed 2014-09-11 | |
| 2011-06-30 | -$5.52M 10-K · filed 2013-09-27 | |
| 2010-06-30 | $12.35M 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |